Mon, Apr 15, 2024

SUZLON Energy: Suzlon Energy’s 30-MW Wind Project Win, Stock Down 3%

Suzlon Energy bags the order of 30MW Wind Power Project for installing Wind turbine generators and  this is use for green energy  instead of Carbon emission, Mainly this project is executed in Gujarat.

SUZLON ENERGY Market Price is moving in Ascending channel and market has reached higher low area of the channel

SUZLON ENERGY Market Price is moving in Ascending channel and market has reached higher low area of the channel

Suzlon Energy’s stock fell 3% on February 29, despite securing a 30-MW wind power project for EDF Renewables. The project in Gujarat involves installing 10 S144‐140m turbines with a 3 MW capacity each, marking a repeat order for Suzlon. The company will handle the entire project, including supply, supervision, erection, commissioning, and post-commissioning operations and maintenance services. JP Chalasani, CEO of Suzlon Group, emphasized the order as a validation of their technology and commitment to delivering clean, renewable energy to Gujarat.

MAN Industries: Man Industries Shares Rise 3% on Rs 555 Crore Orders Win

Man Industries bags the order worth of Rs.555 Crore for manufacturing carbon pipes for Hydrogen transport  in Europe.

MAN INDUSTRIES Market Price is moving in Ascending channel and market has reached higher low area of the channel

MAN INDUSTRIES Market Price is moving in Ascending channel and market has reached higher low area of the channel

Man Industries shares opened at Rs 391, marking a 2.7% increase on February 29, following the acquisition of orders worth Rs 555 crore. The company reported a total unexecuted order book of approximately Rs 2000 crore to be fulfilled in the next 6 months. The recent order pertains to the supply of various types of pipes.

In December 2023, the company announced the successful testing of its pipes for safe hydrogen transport, conducted by a leading European research center. This testing ensures structural integrity and safety for hydrogen fuel transport.

s1

For the quarter ending December 2023, the company’s net profit saw a 17.7% decline, amounting to Rs 30.60 crore. Established in 1988, Man Industries specializes in manufacturing large-diameter carbon steel pipes used in diverse industries such as oil and gas, petrochemicals, water, dredging, and fertilizers.

Sunpharma: “NPPA Sets Retail Prices for 69 Formulations, Reducing Costs of Diabetes and BP Medications”

Diabetes and Hyper tension drugs is capped by Government due to higher prices selling by pharma companies to publics. So Drug companies have to sell the capped prices with Government norms here after.

SUN PHARMACECUTICAL Market Price is moving in Ascending channel and market has reached higher low area of the channel

SUN PHARMACECUTICAL Market Price is moving in Ascending channel and market has reached higher low area of the channel

National Pharmaceutical Pricing Authority (NPPA) Fixes Prices for 69 Formulations, Aiming for Cheaper Diabetes and Hypertension Drugs

The NPPA has set retail prices for 69 formulations and the ceiling cost for 31 formulations, potentially reducing the cost of drugs for diabetes and hypertension. Manufacturers failing to comply with the price cap must refund any overcharged amount to the government.

s3

Under price control are medications for type 2 diabetes, blood pressure, antibiotics, cough syrups, and depression. Notable examples include the combination of dapagliflozin, metformin hydrochloride, and glimepiride tablets priced at around Rs 14 each for type 2 diabetes.

s4

Major pharmaceutical companies like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltd, and Torrent Pharma are included in the list. Additionally, 39 formulations, including Snake venom antiserum, HIV medication Zidovudine, Desferrioxamine for thalassemia, and budesonide-formoterol for asthma, have been brought under price control.

Established in 1997, the NPPA regulates pharmaceutical product prices, enforces the Drug Price Control Order (DPCO), and monitors prices of controlled and decontrolled drugs. Its primary goal is to ensure the availability of essential medicines at reasonable and regulated prices, with a mandate for retailers and dealers to prominently display prices for consumer accessibility.

Reports suggest that the Federation of Pharma Entrepreneurs (FOPE), a leading lobby group, has urged the regulator to temporarily halt a notice warning manufacturers of potential penal actions for introducing new drugs before official price notifications.


Don’t trade all the time, trade forex only at the confirmed trade setups.

Get more confirmed trade setups here: forexgdp.com/buy/

Leave a Reply

Your email address will not be published. Required fields are marked *

Also read

85% Offer for Signals

X